Evidence map›Paper›PMID 30120234›Full record

ArticleNature communications2018

Galectin-9 suppresses B cell receptor signaling and is regulated by I-branching of N-glycans.

N Giovannone, J Liang, A Antonopoulos, J Geddes Sweeney, S L King, S M Pochebit, N Bhattacharyya, G S Lee, A Dell, H R Widlund and 2 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 98 papers.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

98 citing papers in PubMed, 136 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Single-Cell RNA-seq Analysis Reveals Distinct Tumor and Immunosuppressive T-Cell Phenotypes in Patients with CLL Treated with Ibrutinib.Clinical cancer research : an official journal of the American Association for Cancer Research · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Galectin-9 binding to HLA-DR in dendritic cells controls immune synapse formation and T cell proliferation.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  13. Article
  14. Article
  15. Review
  16. Galectin-9-An Emerging Glyco-Immune Checkpoint Target for Cancer Therapy.International journal of molecular sciences · 2025
    Review
  17. Review
  18. Article
  19. Article
  20. Article

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

N GiovannoneDepartment of Dermatology, Brigham and Women's Hospital, Boston, MA, 02115, USA.ORCID http://orcid.org/0000-0001-5391-8729
J LiangDepartment of Dermatology, Brigham and Women's Hospital, Boston, MA, 02115, USA.
A AntonopoulosDepartment of Life Sciences, Imperial College London, London, SW7 2AZ, UK.
J Geddes SweeneyDepartment of Dermatology, Brigham and Women's Hospital, Boston, MA, 02115, USA.
S L KingDepartment of Dermatology, Brigham and Women's Hospital, Boston, MA, 02115, USA.
S M PochebitHarvard Medical School, Boston, MA, 02115, USA.
N BhattacharyyaDepartment of Surgery, Division of Otolaryngology, Brigham and Women's Hospital, Boston, MA, 02115, USA.
G S LeeDepartment of Otology and Laryngology, Harvard Medical School, Boston, MA, 02115, USA.
A DellDepartment of Life Sciences, Imperial College London, London, SW7 2AZ, UK.
H R WidlundDepartment of Dermatology, Brigham and Women's Hospital, Boston, MA, 02115, USA.
S M HaslamDepartment of Life Sciences, Imperial College London, London, SW7 2AZ, UK. s.haslam@imperial.ac.uk.ORCID http://orcid.org/0000-0002-5563-679X
C J DimitroffDepartment of Dermatology, Brigham and Women's Hospital, Boston, MA, 02115, USA. cdimitroff@bwh.harvard.edu.
Brigham and Women's Hospital · USImperial College London · GBHarvard University · US

Funding

Functional Analysis of Galectin-1 Ligands in Melanoma ProgressionR01CA173610 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI DIMITROFF, CHARLES J · 2013 to 2017
$1.8M
Glycomic Characterization of Germinal Center B cellsR21AI125476 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI DIMITROFF, CHARLES J · 2016 to 2017
$451k
Biotechnology and Biological Sciences Research Council BB/F008309/1NCI NIH HHS R01 CA173610NIAID NIH HHS R21 AI125476Wellcome Trust 082098
6 · The paper itself

Abstract

Leukocytes are coated with a layer of heterogeneous carbohydrates (glycans) that modulate immune function, in part by governing specific interactions with glycan-binding proteins (lectins). Although nearly all membrane proteins bear glycans, the identity and function of most of these sugars on leukocytes remain unexplored. Here, we characterize the N-glycan repertoire (N-glycome) of human tonsillar B cells. We observe that naive and memory B cells express an N-glycan repertoire conferring strong binding to the immunoregulatory lectin galectin-9 (Gal-9). Germinal center B cells, by contrast, show sharply diminished binding to Gal-9 due to upregulation of I-branched N-glycans, catalyzed by the β1,6-N-acetylglucosaminyltransferase GCNT2. Functionally, we find that Gal-9 is autologously produced by naive B cells, binds CD45, suppresses calcium signaling via a Lyn-CD22-SHP-1 dependent mechanism, and blunts B cell activation. Thus, our findings suggest Gal-9 intrinsically regulates B cell activation and may differentially modulate BCR signaling at steady state and within germinal centers.

Indexed as

Signal TransductionAmino SugarsB-LymphocytesCalcium SignalingCell LineCell NucleusCell ProliferationEndocytosisGalectinsGerminal CenterHumansImmunologic FactorsImmunologic MemoryLeukocyte Common AntigensLymphocyte ActivationLymphoid TissueAmino SugarsGalectinsGCNT2 protein, humanImmunologic FactorsLeukocyte Common AntigensLGALS9 protein, humanlyn protein-tyrosine kinaseN-AcetylhexosaminyltransferasesN-acetyllactosamineN-Acetylneuraminic AcidPolysaccharidesProtein Tyrosine Phosphatase, Non-Receptor Type 6PTPN6 protein, humanReceptors, Antigen, B-CellSialic Acid Binding Ig-like Lectin 2src-Family Kinases

Identifiers

PMID30120234
PMCPMC6098069
OpenAlexW2887302504

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.